Eli Lilly and Company recently announced that its partner, Junshi Biosciences, dosed the first healthy volunteer in a study of a potential COVID-19 antibody treatment.
For more coronavirus updates,...
A recent analysis of a randomized clinical trial found that the administration of D-cycloserine (DCS) enhanced exposure therapy for social anxiety disorder (SAD) when given before or after the exposure...
A new clinical found that high doses of hydroxychloroquine did not prevent illness compatible with COVID-19 when initiated within four days after a high-risk or moderate-risk exposure.
For more...
FDA recently issued the first emergency use authorization (EUA) for a COVID-19 antigen test for use during the pandemic.
For more coronavirus updates, visit our resource page, updated twice...
An FDA-approved antiviral drug used to treat herpes simplex virus I infection (HSV-1) may be effective for treating plaque formation and other markers of Alzheimer’s disease, according to a new...
A recent COVID-19 clinical trial found that higher dosages of 2 chloroquine diphosphate should not be recommended for critically ill coronavirus patients because of its potential safety...
In response to an FDA and FTC open docket regarding biosimilar marketplace competition, Premier submitted comments and recommendations to further promote a robust biosimilars marketplace.
The...
The American Society of Health-System Pharmacists (ASHP) recently called on the Trump Administration to address shortages of supportive ventilator drugs as COVID-19 continues to infect more...
Gilead will expand access to potential COVID-19 treatment, remdesivir, for patients with the greatest need, according to an official letter from Daniel O’Day, Gilead chairman and CEO.
For more...
Johnson & Johnson recently announced that its Janssen Pharmaceutical Companies have partnered with Beth Israel Deaconess Medical Center (BIDMC) to enhance COVID-19 drug discovery.
For more...
Vivli announced that it recently launched a COVID-19 portal for sharing completed interventional treatment clinical trial data.
For more coronavirus updates, visit our resource page, updated twice...
The Department of Health and Human Services (HHS) recently announced support for a Phase 2/3 clinical trial to evaluate a possible COVID-19 treatment for severely ill patients.
For more coronavirus...
Global specialist HIV company ViiV Healthcare, owned by GSK, and UNC-Chapel Hill recently announced a five-year, $20 million renewal of a public-private partnership to discover a possible HIV...
The FDA issued a new draft guidance evaluating the safety of two new drugs for type 2 diabetes and removing the previous requirement for standardized clinical trials for diabetes drugs.
The...
With COVID-19 continuously spreading throughout the US, the FDA took two major actions to address the virus and enhance its ongoing commitment to the public, according to a recent press release.
For...
Slightly over a third of cancer patients are eligible for immune checkpoint inhibitor (ICI) drugs but even fewer are responding to the innovative treatment, according to researchers from Oklahoma State...
Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued a letter to the Trump Administration’s COVID-19 Task Force affirming pharmacy benefit managers’ (PBMs)...
The city of Marietta has filed a class action lawsuit against drug manufacturer Mallinckrodt, claiming the company increased the price for a specific seizure medication by 97,500 percent, according to...
Clinical trial research is the heartbeat of pharmaceutical drugs and medical devices. This rigorous series of testing, in which researchers look at real-world evidence to determine a treatment or...
